【康婷生物是哪个国家的品牌？】

天津市康婷生物工程有限公司成立于1996年，注册资金1.6亿元，是一家集研发、生产、销售为一体的现代化企业。公司二、三期工程占地面积30亩，总建筑面积30000平米。其中符合GMP标准、GMPC标准的10万级净化化妆品、保健食品车间12000平米；设置有全自动软胶囊生产线4条，全自动包装机多台，全自动灌装线多条，全自动硬胶囊生产线1条；独立的、配有全自动口服液生产线口服液车间1500平米；万级（局百）针剂车间1500平米；大型配货中心3400平米；生物医学研究院面积3400平米，配有世界最先进的实时定量PCR仪、液相芯片系统Luminex、大型分析型流式细胞仪、全波长酶标仪、电脉冲扫描细胞计数器等尖端仪器。公司教育培训中心有大、中、小型会议室；美容培训室可同时容纳64人接受美容培训，宿舍区可接待200名学员住宿。

康婷家人医院建筑面积3400平米，配备世界一流的医疗、检查设备，专为会员提供免费体检、疑难病咨询、医疗等服务。 

2009年6月，康婷公司核心技术项目《微生物发酵法生产透明质酸》获国家科技部创新基金立项，资助资金70万元。

2009年11月，康婷公司《快速响应生产管理信息系统》的启用，再次获得国家科技部40万元的项目专款资助（国科发计〔2009〕598号）

2012年8月，康婷公司《一种微生物发酵法生产透明质酸的方法》获国家发明专利。

2012年11月，康婷公司进入高新技术企业行列。

2012年12月，康婷公司被天津市工商评为“重合同，守信誉”企业。

2012年12月，康婷公司瑞倪维儿商标被天津市工商局评为著名商标。

2012年12月，康婷公司《提高透明质酸发酵产量的工艺研究》项目获科委“产学研合作专项资金”支持35万元。

2013年4月18日，康婷公司获得国家商务部颁发直销经营许可证。

2013年12月，康婷医学研究院3项具有自主知识产权的专利进入了实审阶段。

2014年1月，康婷医学研究院开展的体外诱导干细胞成为胰岛细胞和神经胶质细胞的项目，获得天津市西青科委50万元资金的资助，此项目的开展将会改善医疗界一直以来对于糖尿病和老年痴呆症治标不治本的现状。

十多年来康婷公司一直从事以抗衰老为主题的生物技术的研发生产工作。企业从上到下秉承着“诚实守信，求质创新”的企业文化，励志潜行，抓质量求效益，抓研发求发展。面对着护肤品行业外资垄断的局面，企业的带头人立志要做出属于中国人的百年护肤品牌，为早日研究出“创造需求的产品”而努力奋斗！

未来的康婷将不仅仅满足于自主研发的专利产品，按照公司的二五规划、三五规划，最终实现完成康婷健康产业园的建设；完成海洋生物资源的考察、研究、利用；整合各项资源实现产业的可持续发展；提升品牌世界知名度，增强社会责任感，为全人类健康事业做出更大的贡献！

英文翻译：Founded in 1996 with a registered capital of 160 million yuan, Tianjin Kangting Bioengineering Co., Ltd. is a modern enterprise integrating R & D, production and sales. Phase II and phase III of the company covers an area of 30 mu, with a total construction area of 30000 square meters. Among them, 12000 square meters of 100000 level clean cosmetics and health food workshops are in line with GMP standards and GMPC standards; 4 automatic soft capsule production lines, multiple automatic packaging machines, multiple automatic filling lines and 1 automatic hard capsule production line are set; 1500 square meters of independent oral liquid workshops are equipped with automatic oral liquid production lines; 1500 square meters of 10000 level (Bureau 100) injection workshops are set; large-scale The distribution center covers an area of 3400 square meters; the biomedical research institute covers an area of 3400 square meters, equipped with the world's most advanced real-time quantitative PCR instrument, liquid-phase chip system Luminex, large-scale analytical flow cytometer, full wavelength enzyme labeling instrument, electric pulse scanning cell counter and other cutting-edge instruments. The company's education and training center has large, medium and small conference rooms; the beauty training room can accommodate 64 people to receive beauty training at the same time, and the dormitory area can accommodate 200 students. Kangting family hospital, with a building area of 3400 square meters, is equipped with world-class medical and inspection equipment. It is specially designed to provide members with free physical examination, difficult disease consultation, medical and other services. In June 2009, Kangting company's core technology project "production of hyaluronic acid by microbial fermentation" was approved by the innovation fund of the Ministry of science and technology of the people's Republic of China, with a funding of 700000 yuan. In November 2009, Kangting company's "rapid response production management information system" was put into use, and once again obtained a special fund of 400000 yuan from the Ministry of science and technology of the people's Republic of China (gkfj [2009] No. 598). In August 2012, Kangting company's "a method of producing hyaluronic acid by microbial fermentation" obtained a national invention patent. In November 2012, Kangting company entered the ranks of high-tech enterprises. In December 2012, Kangting company was awarded the title of "contract abiding and credit abiding" enterprise by Tianjin industry and commerce. In December 2012, Ruini Weier trademark of Kangting company was awarded as a famous trademark by Tianjin Administration for Industry and commerce. In December 2012, Kangting company's "technology research on improving the production of hyaluronic acid fermentation" project was supported by the "special fund for industry university research cooperation" of the science and Technology Commission. On April 18, 2013, Kangting company obtained the direct marketing license issued by the Ministry of Commerce of the people's Republic of China. In December 2013, three patents with independent intellectual property rights of Kangting Medical Research Institute entered the stage of trial. In January 2014, Kangting Medical Research Institute launched the project of inducing stem cells into islet cells and glial cells in vitro, which was funded by 500000 yuan from Tianjin Xiqing science and Technology Commission. The development of this project will improve the current situation of treating diabetes and Alzheimer's disease. For more than ten years, Kangting company has been engaged in the research, development and production of biotechnology with the theme of anti-aging. From the top to the bottom, the enterprise adheres to the corporate culture of "honest and trustworthy, seeking quality and innovation", encourages itself to go ahead, strives for quality and efficiency, and strives for development through research and development. In the face of foreign monopoly in the skin care industry, the leaders of the enterprise are determined to make a century old skin care brand belonging to the Chinese people and strive for the early research of "products to create demand"! In the future, Kangting will not only be satisfied with the patent products independently researched and developed, but also ultimately complete the construction of Kangting health industrial park according to the company's five-year plan and three five-year plan; complete the investigation, research and utilization of marine biological resources; integrate various resources to realize the sustainable development of the industry; enhance the world-famous brand, enhance the sense of social responsibility, and do for the cause of human health Greater contribution!

本文链接： https://www.waitui.com/brand/db81ef813.html 联系电话：022-83969871